SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-17-052505
Filing Date
2017-10-16
Accepted
2017-10-16 06:09:40
Documents
2
Group Members
GL CAPITAL MANAGEMENT GP L.P.GL CAPITAL MANAGEMENT GP LTDGL CHINA OPPORTUNITIES FUND L.P.GL TRADE INVESTMENT LTDZHENFU LI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv477011_sc13da.htm SC 13D/A 113514
2 EXHIBIT 15 tv477011_ex15.htm EX-15 14210
  Complete submission text file 0001144204-17-052505.txt   129471
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43408 | Film No.: 171137537
SIC: 2834 Pharmaceutical Preparations

Mailing Address A-31F,GLOBAL TRADE,MANSION 9,GUANGHUA RD BEIJING F4 100020
Business Address A-31F,GLOBAL TRADE,MANSION 9,GUANGHUA RD BEIJING F4 100020 86-010-5961 1212
GL Partners Capital Management Ltd (Filed by) CIK: 0001562291 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A